Yahoo · Oct 6, 2026
AXIM Biotechnologies Submits 510(k) to FDA for Next-Generation, Rapid Point-of-Care Tear Lactoferrin Test for Dry Eye Disease
Simplified, Modernized Lateral-flow Test is Designed to put a Fast, Objective dry eye Measurement Directly in the Hands of eye Care Providers; Company Plans to Pursue CLIA Waiver Following Clearance SAN DIEGO, CA - October 6, 2026 (NEWMEDIAWIRE) - AX...


